Kedalion Therapeutics to Present at Biotech Showcase 2019
MENLO PARK, Calif.--(BUSINESS WIRE)--Kedalion Therapeutics, Inc., a clinical-stage company focused on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream™ platform, today announced that Peter Noymer, PhD, the Company’s President and CEO, will be presenting at the Biotech Showcase 2019 at the Hilton San Francisco Union Square in San Francisco, CA. Details of the presentation are below: Date: Monday, January 7, 2019 Time: 10:30 a.m. PDT